<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Pharm Res</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Pharm Res</journal-id><journal-id journal-id-type="doi">10.5812/ijpr</journal-id><journal-id journal-id-type="publisher-id">Brieflands</journal-id><journal-title-group><journal-title>Iranian Journal of Pharmaceutical Research : IJPR</journal-title></journal-title-group><issn pub-type="ppub">1735-0328</issn><issn pub-type="epub">1726-6890</issn><publisher><publisher-name>Brieflands</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11786116</article-id><article-id pub-id-type="doi">10.5812/ijpr-145620</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>PAG Masked Protective Physical Exercise-Induced High H<sub>2</sub>S Levels in 5/6 Nephrectomized Rats</article-title></title-group><contrib-group><contrib id="idm663f671f2d60c" contrib-type="author"><name><surname>Seifi</surname><given-names>Behjat</given-names></name><email>b-seifi@tums.ac.ir</email><xref rid="aff1" ref-type="aff">1</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2082-968X</contrib-id></contrib><contrib id="idm663f671f2d619" contrib-type="author"><name><surname>Kadkhodaei</surname><given-names>Mehri</given-names></name><email>kadkhodm@tums.ac.ir</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="cor663f671f2d622" ref-type="corresp">*</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0458-6662</contrib-id></contrib><contrib id="idm663f671f2d746" contrib-type="author"><name><surname>Bakhshi</surname><given-names>Enayatollah</given-names></name><email>bakhshi@razi.tums.ac.ir</email><xref rid="aff2" ref-type="aff">2</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8049-0190</contrib-id></contrib><contrib id="idm663f671f2d763" contrib-type="author"><name><surname>Sajedizadeh</surname><given-names>Abdollah</given-names></name><email>mahdihamaye1417@gmail.com</email><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib id="idm663f671f2d76e" contrib-type="author"><name><surname>Ranjbaran</surname><given-names>Mina</given-names></name><email>m-ranjbaran@sina.tums.ac.ir</email><xref rid="aff1" ref-type="aff">1</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4791-8911</contrib-id></contrib><contrib id="idm663f671f2d777" contrib-type="author"><name><surname>Hajiaqaei</surname><given-names>Mahdi</given-names></name><email>mahdihajiaqaei@gmail.com</email><xref rid="aff1" ref-type="aff">1</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6166-3340</contrib-id></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Physiology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran</aff><aff id="aff2"><label>2</label>Department of Statistics and Computer, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran</aff><author-notes><corresp id="cor663f671f2d622"><label>*</label>Corresponding Author: Department of Physiology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Email: <email>kadkhodm@tums.ac.ir</email></corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>5</month><year>2024</year></pub-date><pub-date pub-type="collection"><season>Jan-Dec</season><year>2024</year></pub-date><volume>23</volume><issue>1</issue><elocation-id>e145620</elocation-id><history><date date-type="received"><day>12</day><month>2</month><year>2024</year></date><date date-type="rev-recd"><day>30</day><month>3</month><year>2024</year></date><date date-type="accepted"><day>03</day><month>4</month><year>2024</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2024, Seifi et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Seifi et al</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (<ext-link xlink:href="https://creativecommons.org/licenses/by/4.0/" ext-link-type="uri">https://creativecommons.org/licenses/by/4.0/</ext-link>), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Background</title><p>To investigate the mechanisms of exercise therapeutics in preclinical animal models of chronic kidney disease (CKD), PAG (D, L-propargylglycine), an inhibitor of hydrogen sulfide production, was used to examine the protective effects of physical activity on oxidative stress and inflammation levels during CKD.</p></sec><sec><title>Methods</title><p>Male Wistar rats with CKD, induced by the 5/6 nephrectomy procedure and subjected to 8 weeks of exercise training, received injections of PAG, a cystathionine &#x003b3;-lyase (CSE) inhibitor, at a dose of 19 mg/kg, i.p., twice a week during those 8 weeks. The systolic blood pressure (BP) and renal sympathetic nerve activity (RSNA) were assessed. Additionally, plasma creatinine, BUN, renal hydrogen sulfide (H<sub>2</sub>S) levels, oxidative stress, and inflammatory markers were evaluated.</p></sec><sec><title>Results</title><p>In the PAG group, inhibition of H<sub>2</sub>S production significantly reversed the improvements in plasma creatinine, BUN, renal malondialdehyde (MDA) level, superoxide dismutase (SOD) activity, TNF-&#x003b1;, and IL-6 that were achieved by exercise. Additionally, high RSNA and high BP, which were also reversed in the PAG group, compared to the CKD group subjected to exercise training.</p></sec><sec><title>Conclusions</title><p>The results suggest that the improvement in BP, oxidative stress, and inflammation status by exercise in CKD may be at least partially due to CSE/H<sub>2</sub>S signaling.</p></sec></abstract><kwd-group kwd-group-type="author"><kwd>5/6 Nephrectomy</kwd><kwd>Exercise</kwd><kwd>Hydrogen Sulfide</kwd><kwd>PAG</kwd><kwd>Hypertension</kwd><kwd>RSNA</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>1. Background</title><p>Hydrogen sulfide (H2S) functions as a signaling gas molecule (<xref rid="A145620REF1" ref-type="bibr">1</xref>) and plays essential roles in various biological processes. Studies on hypertensive and ovariectomized rats have shown that exercise increases the levels of hydrogen sulfide in the endothelial cells of the heart and aorta, as well as the expression of the cystathionine &#x003b3;-lyase (CSE) gene, which is crucial for hydrogen sulfide production. In mammals, H<sub>2</sub>S is produced by three key enzymes: Cystathionine &#x003b2;-synthase (CBS), CSE, and 3-mercaptopyruvate sulfur transferase (MST), with CSE being the primary enzyme in the kidney, liver, vascular smooth muscle cells, and endothelial cells. It has been shown that after kidney transplantation, renal CSE correlates with kidney function but not CBS. Hydrogen sulfide levels may decrease in chronic renal disease (<xref rid="A145620REF2" ref-type="bibr">2</xref>). Our observations indicate that long-term NaHS treatment effectively prevents the progression of chronic kidney disease (CKD) by enhancing the balance between oxidants and antioxidants, and by reducing inflammation and apoptosis (<xref rid="A145620REF3" ref-type="bibr">3</xref>). In the kidneys, H<sub>2</sub>S regulates tubular reabsorption of sodium, vasodilation, and glomerular filtration rate (GFR) (<xref rid="A145620REF4" ref-type="bibr">4</xref>). During hypoxic conditions, H<sub>2</sub>S accumulates in the renal medulla, which leads to increased blood volume. Additionally, H<sub>2</sub>S improves renal medulla O<sub>2</sub> supply by directly inhibiting mitochondrial respiration and dilating the descending vasa recta (<xref rid="A145620REF5" ref-type="bibr">5</xref>). Given that medullary hypoxia is a common consequence of CKD (<xref rid="A145620REF6" ref-type="bibr">6</xref>), a deficiency in H<sub>2</sub>S may impair these important adaptive mechanisms.</p><p>Clinical evidence suggests a link between decreased physical activity and deteriorating renal function, underscoring the importance of exploring evidence-supported therapeutic options that focus on nutrition and physical exercise (<xref rid="A145620REF7" ref-type="bibr">7</xref>). A recent study examined the association between adherence to physical activity guidelines for aerobic activity and sedentary time, and their effects on mortality and disease progression among US adults with CKD. It found that increased aerobic activity and reduced sedentary time were associated with decreased mortality and prevention of disease progression (<xref rid="A145620REF8" ref-type="bibr">8</xref>). Additionally, resistance exercise training has been shown to increase muscle size and strength. Given the compromised physical function of patients with CKD, even modest increases in exercise capacity or strength can lead to significant improvements in functional status. Furthermore, physical activity may enhance survival rates or potentially slow the progression of CKD (<xref rid="A145620REF9" ref-type="bibr">9</xref>).</p><p>In a previous study conducted in our lab, a significant increase in renal H<sub>2</sub>S levels was demonstrated following long-term exercise in CKD animals (<xref rid="A145620REF10" ref-type="bibr">10</xref>). In the present study, the CSE enzyme and production of H<sub>2</sub>S were inhibited by D, L-propargylglycine (PAG).</p></sec><sec sec-type="intro"><title>2. Objectives</title><p>Therefore, this study aimed to evaluate the hypothesis that inhibiting H<sub>2</sub>S production via CSE enzyme inhibition could mask the protective effects of physical exercise on renal damage, hypertension, and renal sympathetic nervous activity in preclinical animal models of CKD.</p></sec><sec sec-type="methods"><title>3. Methods</title><p>Male Wistar rats weighing 220 - 250 g were obtained from the Physiology Animal House. This study received ethical approval from the Ethical Committee of Experimental Animals of Tehran University of Medical Sciences under the approval code IR.TUMS.MEDICINE.REC.1395.638.</p><p>Rats were randomly assigned to four groups, with six in each: 1- Sham, 2- CKD, 3- Exercise (Exe), 4- PAG. The induction of CKD was performed using the 5/6 nephrectomy method (<xref rid="A145620REF10" ref-type="bibr">10</xref>). Three weeks post-surgery, the animals began exercising on a treadmill starting at a speed of 10 meters per minute for one week, followed by an increase to 18 meters per minute for an additional eight weeks. In the PAG group, animals received an injection of the CSE enzyme inhibitor (PAG, 19 mg/kg, intraperitoneally, twice a week) for eight weeks.</p><p>A recent recommendation involves the measurement of out-of-office blood pressure (BP) to confirm the diagnosis of hypertension (<xref rid="A145620REF11" ref-type="bibr">11</xref>). Therefore, in two animals from each group, a telemetry transmitter was inserted into the abdominal aorta for continuous arterial BP recording during the last two days of the experiments. At the end of the twelfth week, left renal sympathetic nerve activity (RSNA) was recorded for two hours. In the remaining animals of each group, systolic BP was measured using the Power Lab Tail cuff system.</p><p>At the conclusion of the study, blood and kidney tissue samples were collected to evaluate markers of oxidative stress (levels of MDA and activity of SOD) and inflammatory indices (TNF-&#x003b1; and IL-6 levels).</p><sec><title>3.1. Blood Pressure Transmitter Remote Installation Method</title><p>Two days before the end of the experiments, rats were anesthetized with isoflurane (5%, maintained at a dose of 1 - 3%). The abdomen of each rat was opened to locate the abdominal aorta below the renal arteries within the peritoneal cavity. A catheter transmitter (TRM54p) was then inserted into the aorta and advanced up to the renal arteries. The catheter was secured to the aorta using tissue glue. After the glue dried, the transmitter device was positioned right in front of the animal's abdomen, ensuring it made contact with the ground. Surgical mesh around the transmitter was sutured to the subcutaneous layer. The skin and other layers were then sutured closed. Analgesic and antibiotic drugs were administered intramuscularly. Subsequently, each animal was placed separately on a pad (SmartPad, TR180) connected to a Configurator (TR190) for continuous recording of BP and heart rate. The PowerLab system and LabChart software recorded the signals. Blood pressure was recorded for 10 seconds every 2 minutes at a frequency of 500 Hz over those two days.</p></sec><sec><title>3.2. Renal Sympathetic Nerve Activity Recording Method</title><p>To record the activity of the renal sympathetic nerve, on the final day of the experiments, the left renal nerve was exposed using an optical microscope. The nerve was positioned on a pair of silver electrodes. Once an acceptable signal-to-noise ratio was achieved, vaseline oil was applied to cover both the nerve and the electrodes. Nerve signals were then amplified by an AC/DC amplifier with low and high frequency cutoffs set at 30 - 3000 Hz. Amplified signals were integrated with a time constant of 20 seconds. The PowerLab data acquisition system was used to concurrently record both raw and integrated RSNA.</p></sec><sec><title>3.3. Inflammatory Indices Assessments</title><p>Tumor necrosis factor-alpha (TNF-&#x003b1;) and interleukin-6 (IL-6) concentrations were measured in plasma samples using ELISA.</p></sec><sec><title>3.4. Renal Oxidative Stress Assessments</title><p>Malondialdehyde (MDA) levels and superoxide dismutase (SOD) activity were measured in the supernatant of kidney tissue homogenates. Malondialdehyde levels were assessed according to the method described by Esterbauer and Cheeseman (<xref rid="A145620REF12" ref-type="bibr">12</xref>). The technique developed by Paoletti and Mocali was used to measure SOD activity (<xref rid="A145620REF13" ref-type="bibr">13</xref>).</p></sec><sec><title>3.5. Measurement of Renal Hydrogen Sulfide Levels</title><p>Hydrogen sulfide concentration in the kidney tissues was measured using methods previously described (<xref rid="A145620REF14" ref-type="bibr">14</xref>).</p></sec><sec><title>3.6. Statistical Analysis</title><p>Data are expressed as mean &#x000b1; SEM. One-way ANOVA followed by a post hoc Tukey's test was used. The significance level was set at P &#x0003c; 0.05.</p></sec></sec><sec sec-type="results"><title>4. Results</title><sec><title>4.1. Effect of PAG on the Beneficial Effects of the Exercise</title><p>Eight weeks of PAG administration along with physical exercise resulted in significantly higher plasma creatinine and BUN levels compared to the exercise-only group (<xref rid="A145620FIG1" ref-type="fig">Figure 1</xref>, P &#x0003c; 0.05).</p><fig position="float" id="A145620FIG1" fig-type="inline"><label>Figure 1.</label><caption><title>A, changes in plasma creatinine; and B, BUN in different groups. Data are presented as Mean &#x000b1; SEM. Chronic kidney disease (CKD), 5/6 Nx; Exe, 5/6 Nx + exercise; PAG, 5/6 Nx + exercise + D L-propargylglycine.* P &#x0003c; 0.05 significance differences with Sham group. # P &#x0003c; 0.05 significance differences with CKD group. &#x00026; P &#x0003c; 0.05 significance differences with Exe group.</title></caption><graphic xlink:href="ijpr-23-1-145620-i001" position="float"/></fig><p>PAG administration combined with physical exercise led to significantly lower renal SOD activity and MDA levels compared to the exercise-only group (<xref rid="A145620FIG2" ref-type="fig">Figure 2</xref>, P &#x0003c; 0.05).</p><fig position="float" id="A145620FIG2" fig-type="inline"><label>Figure 2.</label><caption><title>A, changes in renal superoxide dismutase (SOD) activity; B, malondialdehyde (MDA) level and hydrogen sulfide (H<sub>2</sub>S) level; C, in different groups. Data are presented as Mean &#x000b1; SEM. Chronic kidney disease (CKD), 5/6 Nx; Exe, 5/6 Nx + exercise; PAG, 5/6 Nx+exercise+D, L-propargylglycine.* P &#x0003c; 0.05 significance differences with Sham group. # P &#x0003c; 0.05 significance differences with CKD group. &#x00026; P &#x0003c; 0.05 significance differences with Exe group.</title></caption><graphic xlink:href="ijpr-23-1-145620-i002" position="float"/></fig><p>Additionally, PAG administration along with physical exercise resulted in a significantly lower renal H<sub>2</sub>S level compared to the exercise-only group (<xref rid="A145620FIG2" ref-type="fig">Figure 2</xref>, P &#x0003c; 0.05).</p><p>PAG administration combined with physical exercise also resulted in significantly higher systolic BP and RSNA compared to the exercise-only group (<xref rid="A145620FIG3" ref-type="fig">Figure 3A and C</xref> , P &#x0003c; 0.05).</p><fig position="float" id="A145620FIG3" fig-type="inline"><label>Figure 3.</label><caption><title>A, changes in systolic blood pressure (BP) in the end of 8 weeks; B, SBP monitoring for the last 48 hours; and C, renal sympathetic nerve activity (RSNA) in different groups. Data are presented as Mean &#x000b1; SEM. Chronic kidney disease (CKD), 5/6 Nx; Exe, 5/6 Nx+exercise; PAG, 5/6 Nx + exercise + D, L-propargylglycine.* P &#x0003c; 0.05 significance differences with Sham group. # P &#x0003c; 0.05 significance differences with CKD group. &#x00026; P &#x0003c; 0.05 significance differences with Exe group.</title></caption><graphic xlink:href="ijpr-23-1-145620-i003" position="float"/></fig><p>Telemetry BP monitoring was performed in two rats to further characterize the effects of PAG on the benefits of exercise training on systolic arterial BP during CKD-induced hypertension. Similar to observations made using the tail cuff method, administration of PAG led to an average increase of 30 - 40 mmHg in systolic BP over 48 hours of monitoring (<xref rid="A145620FIG3" ref-type="fig">Figure 3B</xref>). Consistent with the tail-cuff method data, PAG counteracted the protective effects of exercise training against hypertension, such that by the end of the 8-week treatment period, BP had returned nearly to the levels seen in the CKD group.</p><p>Eight weeks of PAG administration along with physical exercise resulted in significantly higher renal TNF-&#x003b1; and IL-6 levels compared to the exercise-only group (<xref rid="A145620FIG4" ref-type="fig">Figure 4</xref>, P &#x0003c; 0.05).</p><fig position="float" id="A145620FIG4" fig-type="inline"><label>Figure 4.</label><caption><title>A, Changes in renal TNF-&#x003b1;; B, and IL-6 levels in different groups. Data are presented as Mean &#x000b1; SEM. Chronic kidney disease (CKD), 5/6 Nx; Exe, 5/6 Nx + exercise; PAG, 5/6 Nx + exercise + D; L-propargylglycine.* P &#x0003c; 0.05 significance differences with Sham group. # P &#x0003c; 0.05 significance differences with CKD group. &#x00026; P &#x0003c; 0.05 significance differences with Exe group.</title></caption><graphic xlink:href="ijpr-23-1-145620-i004" position="float"/></fig></sec></sec><sec sec-type="discussion"><title>5. Discussion</title><p>The main finding of this study was that in the kidneys, inhibition of CSE-mediated H<sub>2</sub>S formation masked the beneficial effects of physical exercise in 5/6 nephrectomized rats. Physical exercise was found to restore renal H<sub>2</sub>S levels. Recent research demonstrated that exercise training increased the expression of CBS/CSE and enhanced endogenous H<sub>2</sub>S production in the renal tissues of diabetic nephropathy (<xref rid="A145620REF15" ref-type="bibr">15</xref>). Additionally, it was observed that both H<sub>2</sub>S and the expression of Nrf2-related antioxidant pathways increased following exercise training. However, blockade of CSE by PAG in this study resulted in lower H<sub>2</sub>S levels, which deteriorated renal function. Consistent with this, Bos et al. reported that CSE deficiency was associated with increased mortality, and the administration of exogenous H<sub>2</sub>S rescued mice from ischemic injury and eventual death (<xref rid="A145620REF16" ref-type="bibr">16</xref>). In this study, physical exercise increased renal H<sub>2</sub>S levels and SOD activity, while decreasing MDA production and TNF-&#x003b1; and IL-6 levels in the remnant kidney tissues. Inflammatory cytokines play significant roles in the development and progression of CKD (<xref rid="A145620REF17" ref-type="bibr">17</xref>). Our data similarly indicated that cytokine levels were significantly higher and that PAG masked the positive effects of exercise on oxidative stress and inflammation. Given that physical exercise resulted in increases in renal H<sub>2</sub>S levels, we suggest that these positive effects may be a result of an increase in renal CSE activities.</p><p>It is well known that H<sub>2</sub>S decreases BP in experimental models of hypertension (<xref rid="A145620REF18" ref-type="bibr">18</xref>). A deficiency in H<sub>2</sub>S-producing enzymes leads to high BP, while the use of H<sub>2</sub>S donors reduces BP and provides protection against organ damage. Since H<sub>2</sub>S may increase the sensitivity of carotid sinus baroreflexes (<xref rid="A145620REF19" ref-type="bibr">19</xref>), it has been demonstrated that exogenous H<sub>2</sub>S inhibits sympathetic outflow in this area (<xref rid="A145620REF20" ref-type="bibr">20</xref>). The results of the present study suggest that the high H<sub>2</sub>S levels induced by physical exercise may decrease BP by reducing sympathetic activation through the reduction of oxidative stress and inflammation. Treatment of hypertensive rats with thiosulfate resulted in lower BP and decreased organ damage (<xref rid="A145620REF21" ref-type="bibr">21</xref>). Oxidative stress and inflammatory cytokines are implicated as important factors in triggering increased sympathetic activity and the development of high BP (<xref rid="A145620REF22" ref-type="bibr">22</xref>). During hypertension, renal denervation has proven to be effective in reducing BP. Sensory information from the kidney is integrated at the level of pre-autonomic neurons within the hypothalamic nuclei (<xref rid="A145620REF23" ref-type="bibr">23</xref>). It is possible that in CKD, tonic activation of the central chemo-reflex pathways may impair this reflex, leading to further increases in RSNA. It was demonstrated that abnormally muscle reflex-evoked increases in sympathetic activity mediate exaggerations in BP (<xref rid="A145620REF24" ref-type="bibr">24</xref>).</p><p>In the present study, direct recording of BP in freely moving and conscious rats overcame many of the limitations associated with other indirect assessments of BP. In a study with conscious CKD rats, Salman et al. described direct telemetric recording of sympathetic nerve activity (SNA) to the kidney and presented evidence that high BP is significantly correlated with increased RSNA and decreased renal function (<xref rid="A145620REF25" ref-type="bibr">25</xref>). Increased sympathetic activity directed towards the CKD kidney may play a significant role in the long-term regulation of BP (<xref rid="A145620REF26" ref-type="bibr">26</xref>). Therefore, during CKD, sympathetic overdrive may contribute to the resistant hypertensive state. Further investigation is needed to clarify how the inhibition of H<sub>2</sub>S production and the use of H<sub>2</sub>S donors can achieve similar outcomes on the protective effects of exercise in CKD.</p><sec><title>5.1. Conclusions</title><p>The data from the present study demonstrate that reduced H<sub>2</sub>S production might be associated with increases in oxidative stress and inflammation, which prevent the protective effects of physical exercise on CKD. Our findings suggest that the high H<sub>2</sub>S level induced by physical exercise may decrease hypertension in CKD by reducing sympathetic activation through the reduction of oxidative stress and inflammation, and this effect might be partially CSE/H<sub>2</sub>S dependent.</p></sec></sec></body><back><ack><p>Many thanks to Tehran University of Medical Sciences for supporting our study.</p></ack><ref-list><ref id="A145620REF1"><label>1</label><element-citation publication-type="journal" publication-format="print" xlink:title=""><person-group person-group-type="author"><name><surname>Koning</surname><given-names>AM</given-names></name><name><surname>Frenay</surname><given-names>AR</given-names></name><name><surname>Leuvenink</surname><given-names>HG</given-names></name><name><surname>van Goor</surname><given-names>H</given-names></name></person-group><article-title>Hydrogen sulfide in renal physiology, disease and transplantation--the smell of renal protection.</article-title><source>Nitric Oxide.</source><year>2015</year><volume>46</volume><fpage>37</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.niox.2015.01.005</pub-id><pub-id pub-id-type="pmid">25656225</pub-id>
</element-citation></ref><ref id="A145620REF2"><label>2</label><element-citation publication-type="journal" publication-format="print" xlink:title="1.Koning AM, Frenay AR, Leuvenink HG, van Goor H. Hydrogen sulfide in renal physiology, disease and transplantation--the smell of renal protection. Nitric Oxide. 2015;46:37-49. [PubMed ID:25656225]. ."><person-group person-group-type="author"><name><surname>Garle</surname><given-names>M</given-names></name><name><surname>John</surname><given-names>S</given-names></name><name><surname>Anderson</surname><given-names>S</given-names></name><name><surname>Ralevic</surname><given-names>V</given-names></name><name><surname>McIntyre</surname><given-names>C</given-names></name><name><surname>O&#x02019;Sullivan</surname><given-names>S</given-names></name></person-group><article-title>P16 Plasma hydrogen sulfide (H2S) levels in CKD patients.</article-title><source>Nitric Oxide.</source><year>2013</year><volume>31</volume><elocation-id>S41</elocation-id><pub-id pub-id-type="doi">10.1016/j.niox.2013.06.078</pub-id></element-citation></ref><ref id="A145620REF3"><label>3</label><element-citation publication-type="journal" publication-format="print" xlink:title="Garle M, John S, Anderson S, Ralevic V, McIntyre C, O&#x02019;Sullivan S. P16 Plasma hydrogen sulfide (H2S) levels in CKD patients. Nitric Oxide. 2013;31:S41. ."><person-group person-group-type="author"><name><surname>Askari</surname><given-names>H</given-names></name><name><surname>Seifi</surname><given-names>B</given-names></name><name><surname>Kadkhodaee</surname><given-names>M</given-names></name><name><surname>Sanadgol</surname><given-names>N</given-names></name><name><surname>Elshiekh</surname><given-names>M</given-names></name><name><surname>Ranjbaran</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>Protective effects of hydrogen sulfide on chronic kidney disease by reducing oxidative stress, inflammation and apoptosis.</article-title><source>Excli j.</source><year>2018</year><volume>17</volume><fpage>14</fpage><lpage>23</lpage><!--<pub-id pub-id-type="pmcid">PMC5780625</pub-id>--><pub-id pub-id-type="doi">10.17179/excli2017-711</pub-id><pub-id pub-id-type="pmid">29383015</pub-id>
</element-citation></ref><ref id="A145620REF4"><label>4</label><element-citation publication-type="journal" publication-format="print" xlink:title="Askari H, Seifi B, Kadkhodaee M, Sanadgol N, Elshiekh M, Ranjbaran M, et al. Protective effects of hydrogen sulfide on chronic kidney disease by reducing oxidative stress, inflammation and apoptosis. Excli j. 2018;17:14-23. [PubMed ID:29383015]. [PubMed Central ID:PMC5780625]. ."><person-group person-group-type="author"><name><surname>Xia</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Muh</surname><given-names>RW</given-names></name><name><surname>Li</surname><given-names>PL</given-names></name><name><surname>Li</surname><given-names>N</given-names></name></person-group><article-title>Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys.</article-title><source>J Pharmacol Exp Ther.</source><year>2009</year><volume>329</volume><issue>3</issue><fpage>1056</fpage><lpage>62</lpage><!--<pub-id pub-id-type="pmcid">PMC2683781</pub-id>--><pub-id pub-id-type="doi">10.1124/jpet.108.149963</pub-id><pub-id pub-id-type="pmid">19246614</pub-id>
</element-citation></ref><ref id="A145620REF5"><label>5</label><element-citation publication-type="journal" publication-format="print" xlink:title="Xia M, Chen L, Muh RW, Li PL, Li N. Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys. J Pharmacol Exp Ther. 2009;329(3):1056-62. [PubMed ID:19246614]. [PubMed Central ID:PMC2683781]. ."><person-group person-group-type="author"><name><surname>Beltowski</surname><given-names>J</given-names></name></person-group><article-title>Hypoxia in the renal medulla: implications for hydrogen sulfide signaling.</article-title><source>J Pharmacol Exp Ther.</source><year>2010</year><volume>334</volume><issue>2</issue><fpage>358</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1124/jpet.110.166637</pub-id><pub-id pub-id-type="pmid">20427475</pub-id>
</element-citation></ref><ref id="A145620REF6"><label>6</label><element-citation publication-type="journal" publication-format="print" xlink:title="Beltowski J. Hypoxia in the renal medulla: implications for hydrogen sulfide signaling. J Pharmacol Exp Ther. 2010;334(2):358-63. [PubMed ID:20427475]. ."><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Nangaku</surname><given-names>M</given-names></name></person-group><article-title>The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease.</article-title><source>Curr Opin Nephrol Hypertens.</source><year>2010</year><volume>19</volume><issue>1</issue><fpage>43</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1097/MNH.0b013e3283328eed</pub-id><pub-id pub-id-type="pmid">19779337</pub-id>
</element-citation></ref><ref id="A145620REF7"><label>7</label><element-citation publication-type="journal" publication-format="print" xlink:title="Tanaka T, Nangaku M. The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease. Curr Opin Nephrol Hypertens. 2010;19(1):43-50. [PubMed ID:19779337]. ."><person-group person-group-type="author"><name><surname>Nishi</surname><given-names>H</given-names></name><name><surname>Takemura</surname><given-names>K</given-names></name><name><surname>Higashihara</surname><given-names>T</given-names></name><name><surname>Inagi</surname><given-names>R</given-names></name></person-group><article-title>Uremic Sarcopenia: Clinical Evidence and Basic Experimental Approach.</article-title><source>Nutrients.</source><year>2020</year><volume>12</volume><issue>6</issue><!--<pub-id pub-id-type="pmcid">PMC7353433</pub-id>--><pub-id pub-id-type="doi">10.3390/nu12061814</pub-id><pub-id pub-id-type="pmid">32570738</pub-id>
</element-citation></ref><ref id="A145620REF8"><label>8</label><element-citation publication-type="journal" publication-format="print" xlink:title="Nishi H, Takemura K, Higashihara T, Inagi R. Uremic Sarcopenia: Clinical Evidence and Basic Experimental Approach. Nutrients. 2020;12(6). [PubMed ID:32570738]. [PubMed Central ID:PMC7353433]. ."><person-group person-group-type="author"><name><surname>Qu</surname><given-names>X</given-names></name><name><surname>Tong</surname><given-names>X</given-names></name><name><surname>Hou</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Hou</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>Trends in Adherence to Recommended Physical Activity and Its Association with Mortality and Disease Progression among US Adults with Chronic Kidney Disease.</article-title><source>Am J Nephrol.</source><year>2022</year><volume>53</volume><issue>8-9</issue><fpage>591</fpage><lpage>602</lpage><!--<pub-id pub-id-type="pmcid">PMC9808653</pub-id>--><pub-id pub-id-type="doi">10.1159/000526956</pub-id><pub-id pub-id-type="pmid">36349764</pub-id>
</element-citation></ref><ref id="A145620REF9"><label>9</label><element-citation publication-type="journal" publication-format="print" xlink:title="Qu X, Tong X, Hou X, Zhang J, Hou L, Chen J. Trends in Adherence to Recommended Physical Activity and Its Association with Mortality and Disease Progression among US Adults with Chronic Kidney Disease. Am J Nephrol. 2022;53(8-9):591-602. [PubMed ID:36349764]. [PubMed Central ID:PMC9808653]. ."><person-group person-group-type="author"><name><surname>Johansen</surname><given-names>KL</given-names></name></person-group><article-title>From People to Lab Rats to People-Study of Exercise in CKD.</article-title><source>J Am Soc Nephrol.</source><year>2019</year><volume>30</volume><issue>10</issue><fpage>1777</fpage><lpage>8</lpage><!--<pub-id pub-id-type="pmcid">PMC6779350</pub-id>--><pub-id pub-id-type="doi">10.1681/ASN.2019080822</pub-id><pub-id pub-id-type="pmid">31501356</pub-id>
</element-citation></ref><ref id="A145620REF10"><label>10</label><element-citation publication-type="journal" publication-format="print" xlink:title="Johansen KL. From People to Lab Rats to People-Study of Exercise in CKD. J Am Soc Nephrol. 2019;30(10):1777-8. [PubMed ID:31501356]. [PubMed Central ID:PMC6779350]. ."><person-group person-group-type="author"><name><surname>Seifi</surname><given-names>B</given-names></name><name><surname>Sajedizadeh</surname><given-names>A</given-names></name><name><surname>Kadkhodaee</surname><given-names>M</given-names></name><name><surname>Ranjbaran</surname><given-names>M</given-names></name></person-group><article-title>Long-term exercise restores hydrogen sulfide in the kidney and contributes to exercise benefits in 5/6 nephrectomized rats.</article-title><source>Clin Exp Hypertens.</source><year>2019</year><volume>41</volume><issue>1</issue><fpage>87</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1080/10641963.2018.1445752</pub-id><pub-id pub-id-type="pmid">29521543</pub-id>
</element-citation></ref><ref id="A145620REF11"><label>11</label><element-citation publication-type="journal" publication-format="print" xlink:title="Seifi B, Sajedizadeh A, Kadkhodaee M, Ranjbaran M. Long-term exercise restores hydrogen sulfide in the kidney and contributes to exercise benefits in 5/6 nephrectomized rats. Clin Exp Hypertens. 2019;41(1):87-91. [PubMed ID:29521543]. ."><person-group person-group-type="author"><name><surname>Drawz</surname><given-names>PE</given-names></name><name><surname>Beddhu</surname><given-names>S</given-names></name><name><surname>Kramer</surname><given-names>HJ</given-names></name><name><surname>Rakotz</surname><given-names>M</given-names></name><name><surname>Rocco</surname><given-names>MV</given-names></name><name><surname>Whelton</surname><given-names>PK</given-names></name></person-group><article-title>Blood Pressure Measurement: A KDOQI Perspective.</article-title><source>Am J Kidney Dis.</source><year>2020</year><volume>75</volume><issue>3</issue><fpage>426</fpage><lpage>34</lpage><!--<pub-id pub-id-type="pmcid">PMC7338147</pub-id>--><pub-id pub-id-type="doi">10.1053/j.ajkd.2019.08.030</pub-id><pub-id pub-id-type="pmid">31864820</pub-id>
</element-citation></ref><ref id="A145620REF12"><label>12</label><element-citation publication-type="journal" publication-format="print" xlink:title="Drawz PE, Beddhu S, Kramer HJ, Rakotz M, Rocco MV, Whelton PK. Blood Pressure Measurement: A KDOQI Perspective. Am J Kidney Dis. 2020;75(3):426-34. [PubMed ID:31864820]. [PubMed Central ID:PMC7338147]. ."><person-group person-group-type="author"><name><surname>Esterbauer</surname><given-names>H</given-names></name><name><surname>Cheeseman</surname><given-names>KH</given-names></name></person-group><article-title>Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal.</article-title><source>Methods Enzymol.</source><year>1990</year><volume>186</volume><fpage>407</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/0076-6879(90)86134-h</pub-id><pub-id pub-id-type="pmid">2233308</pub-id>
</element-citation></ref><ref id="A145620REF13"><label>13</label><element-citation publication-type="journal" publication-format="print" xlink:title="Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990;186:407-21. [PubMed ID:2233308]. ."><person-group person-group-type="author"><name><surname>Paoletti</surname><given-names>F</given-names></name><name><surname>Mocali</surname><given-names>A</given-names></name></person-group><article-title>Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation.</article-title><source>Methods Enzymol.</source><year>1990</year><volume>186</volume><fpage>209</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/0076-6879(90)86110-h</pub-id><pub-id pub-id-type="pmid">2233293</pub-id>
</element-citation></ref><ref id="A145620REF14"><label>14</label><element-citation publication-type="journal" publication-format="print" xlink:title="Paoletti F, Mocali A. Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation. Methods Enzymol. 1990;186:209-20. [PubMed ID:2233293]. ."><person-group person-group-type="author"><name><surname>Mok</surname><given-names>YY</given-names></name><name><surname>Atan</surname><given-names>MS</given-names></name><name><surname>Yoke Ping</surname><given-names>C</given-names></name><name><surname>Zhong Jing</surname><given-names>W</given-names></name><name><surname>Bhatia</surname><given-names>M</given-names></name><name><surname>Moochhala</surname><given-names>S</given-names></name><etal>et al.</etal></person-group><article-title>Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis.</article-title><source>Br J Pharmacol.</source><year>2004</year><volume>143</volume><issue>7</issue><fpage>881</fpage><lpage>9</lpage><!--<pub-id pub-id-type="pmcid">PMC1575944</pub-id>--><pub-id pub-id-type="doi">10.1038/sj.bjp.0706014</pub-id><pub-id pub-id-type="pmid">15504752</pub-id>
</element-citation></ref><ref id="A145620REF15"><label>15</label><element-citation publication-type="journal" publication-format="print" xlink:title="Mok YY, Atan MS, Yoke Ping C, Zhong Jing W, Bhatia M, Moochhala S, et al. Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis. Br J Pharmacol. 2004;143(7):881-9. [PubMed ID:15504752]. [PubMed Central ID:PMC1575944]. ."><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>DX</given-names></name><name><surname>Cao</surname><given-names>BQ</given-names></name><name><surname>Liu</surname><given-names>SJ</given-names></name><name><surname>Xu</surname><given-names>DH</given-names></name><name><surname>Zhu</surname><given-names>XY</given-names></name><etal>et al.</etal></person-group><article-title>Exercise training ameliorates early diabetic kidney injury by regulating the H(2) S/SIRT1/p53 pathway.</article-title><source>FASEB J.</source><year>2021</year><volume>35</volume><issue>9</issue><elocation-id>e21823</elocation-id><pub-id pub-id-type="doi">10.1096/fj.202100219R</pub-id><pub-id pub-id-type="pmid">34396581</pub-id>
</element-citation></ref><ref id="A145620REF16"><label>16</label><element-citation publication-type="journal" publication-format="print" xlink:title="Yang L, Li DX, Cao BQ, Liu SJ, Xu DH, Zhu XY, et al. Exercise training ameliorates early diabetic kidney injury by regulating the H(2) S/SIRT1/p53 pathway. FASEB J. 2021;35(9):e21823. [PubMed ID:34396581]. ."><person-group person-group-type="author"><name><surname>Bos</surname><given-names>EM</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Snijder</surname><given-names>PM</given-names></name><name><surname>Boersema</surname><given-names>M</given-names></name><name><surname>Damman</surname><given-names>J</given-names></name><name><surname>Fu</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>Cystathionine gamma-lyase protects against renal ischemia/reperfusion by modulating oxidative stress.</article-title><source>J Am Soc Nephrol.</source><year>2013</year><volume>24</volume><issue>5</issue><fpage>759</fpage><lpage>70</lpage><!--<pub-id pub-id-type="pmcid">PMC3636788</pub-id>--><pub-id pub-id-type="doi">10.1681/ASN.2012030268</pub-id><pub-id pub-id-type="pmid">23449534</pub-id>
</element-citation></ref><ref id="A145620REF17"><label>17</label><element-citation publication-type="journal" publication-format="print" xlink:title="Bos EM, Wang R, Snijder PM, Boersema M, Damman J, Fu M, et al. Cystathionine gamma-lyase protects against renal ischemia/reperfusion by modulating oxidative stress. J Am Soc Nephrol. 2013;24(5):759-70. [PubMed ID:23449534]. [PubMed Central ID:PMC3636788]. ."><person-group person-group-type="author"><name><surname>Tbahriti</surname><given-names>HF</given-names></name><name><surname>Meknassi</surname><given-names>D</given-names></name><name><surname>Moussaoui</surname><given-names>R</given-names></name><name><surname>Messaoudi</surname><given-names>A</given-names></name><name><surname>Zemour</surname><given-names>L</given-names></name><name><surname>Kaddous</surname><given-names>A</given-names></name><etal>et al.</etal></person-group><article-title>Inflammatory status in chronic renal failure: The role of homocysteinemia and pro-inflammatory cytokines.</article-title><source>World J Nephrol.</source><year>2013</year><volume>2</volume><issue>2</issue><fpage>31</fpage><lpage>7</lpage><!--<pub-id pub-id-type="pmcid">PMC3782222</pub-id>--><pub-id pub-id-type="doi">10.5527/wjn.v2.i2.31</pub-id><pub-id pub-id-type="pmid">24175263</pub-id>
</element-citation></ref><ref id="A145620REF18"><label>18</label><element-citation publication-type="journal" publication-format="print" xlink:title="Tbahriti HF, Meknassi D, Moussaoui R, Messaoudi A, Zemour L, Kaddous A, et al. Inflammatory status in chronic renal failure: The role of homocysteinemia and pro-inflammatory cytokines. World J Nephrol. 2013;2(2):31-7. [PubMed ID:24175263]. [PubMed Central ID:PMC3782222]. ."><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>FU</given-names></name><name><surname>Sattar</surname><given-names>MA</given-names></name><name><surname>Rathore</surname><given-names>HA</given-names></name><name><surname>Abdullah</surname><given-names>MH</given-names></name><name><surname>Tan</surname><given-names>S</given-names></name><name><surname>Abdullah</surname><given-names>NA</given-names></name><etal>et al.</etal></person-group><article-title>Exogenous hydrogen sulfide (H2S) reduces blood pressure and prevents the progression of diabetic nephropathy in spontaneously hypertensive rats.</article-title><source>Ren Fail.</source><year>2012</year><volume>34</volume><issue>2</issue><fpage>203</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.3109/0886022X.2011.643365</pub-id><pub-id pub-id-type="pmid">22229751</pub-id>
</element-citation></ref><ref id="A145620REF19"><label>19</label><element-citation publication-type="journal" publication-format="print" xlink:title="Ahmad FU, Sattar MA, Rathore HA, Abdullah MH, Tan S, Abdullah NA, et al. Exogenous hydrogen sulfide (H2S) reduces blood pressure and prevents the progression of diabetic nephropathy in spontaneously hypertensive rats. Ren Fail. 2012;34(2):203-10. [PubMed ID:22229751]. ."><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>YM</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>YX</given-names></name><name><surname>Wang</surname><given-names>FW</given-names></name><name><surname>He</surname><given-names>RR</given-names></name></person-group><article-title>Hydrogen sulfide facilitates carotid sinus baroreceptor activity in anesthetized male rats.</article-title><source>Chin Med J (Engl).</source><year>2007</year><volume>120</volume><issue>15</issue><fpage>1343</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17711741</pub-id>
</element-citation></ref><ref id="A145620REF20"><label>20</label><element-citation publication-type="journal" publication-format="print" xlink:title="Xiao L, Wu YM, Wang R, Liu YX, Wang FW, He RR. Hydrogen sulfide facilitates carotid sinus baroreceptor activity in anesthetized male rats. Chin Med J (Engl). 2007;120(15):1343-7. [PubMed ID:17711741]."><person-group person-group-type="author"><name><surname>Guo</surname><given-names>Q</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Xue</surname><given-names>H</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Jin</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name></person-group><article-title>Perfusion of isolated carotid sinus with hydrogen sulfide attenuated the renal sympathetic nerve activity in anesthetized male rats.</article-title><source>Physiol Res.</source><year>2016</year><volume>65</volume><issue>3</issue><fpage>413</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.33549/physiolres.933050</pub-id><pub-id pub-id-type="pmid">26988151</pub-id>
</element-citation></ref><ref id="A145620REF21"><label>21</label><element-citation publication-type="journal" publication-format="print" xlink:title="Guo Q, Wu Y, Xue H, Xiao L, Jin S, Wang R. Perfusion of isolated carotid sinus with hydrogen sulfide attenuated the renal sympathetic nerve activity in anesthetized male rats. Physiol Res. 2016;65(3):413-23. [PubMed ID:26988151]. ."><person-group person-group-type="author"><name><surname>Van Goor</surname><given-names>H</given-names></name><name><surname>Van den Born</surname><given-names>JC</given-names></name><name><surname>Hillebrands</surname><given-names>JL</given-names></name><name><surname>Joles</surname><given-names>JA</given-names></name></person-group><article-title>Hydrogen sulfide in hypertension.</article-title><source>Curr Opin Nephrol Hypertens.</source><year>2016</year><volume>25</volume><issue>2</issue><fpage>107</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1097/MNH.0000000000000206</pub-id><pub-id pub-id-type="pmid">26808704</pub-id>
</element-citation></ref><ref id="A145620REF22"><label>22</label><element-citation publication-type="journal" publication-format="print" xlink:title="Van Goor H, Van den Born JC, Hillebrands JL, Joles JA. Hydrogen sulfide in hypertension. Curr Opin Nephrol Hypertens. 2016;25(2):107-13. [PubMed ID:26808704]. ."><person-group person-group-type="author"><name><surname>Su</surname><given-names>Q</given-names></name><name><surname>Qin</surname><given-names>DN</given-names></name><name><surname>Wang</surname><given-names>FX</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>HB</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>Inhibition of reactive oxygen species in hypothalamic paraventricular nucleus attenuates the renin-angiotensin system and proinflammatory cytokines in hypertension.</article-title><source>Toxicol Appl Pharmacol.</source><year>2014</year><volume>276</volume><issue>2</issue><fpage>115</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.taap.2014.02.002</pub-id><pub-id pub-id-type="pmid">24576725</pub-id>
</element-citation></ref><ref id="A145620REF23"><label>23</label><element-citation publication-type="journal" publication-format="print" xlink:title="Su Q, Qin DN, Wang FX, Ren J, Li HB, Zhang M, et al. Inhibition of reactive oxygen species in hypothalamic paraventricular nucleus attenuates the renin-angiotensin system and proinflammatory cytokines in hypertension. Toxicol Appl Pharmacol. 2014;276(2):115-20. [PubMed ID:24576725]. ."><person-group person-group-type="author"><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Zheng</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Patel</surname><given-names>KP</given-names></name></person-group><article-title>Activation of afferent renal nerves modulates RVLM-projecting PVN neurons.</article-title><source>Am J Physiol Heart Circ Physiol.</source><year>2015</year><volume>308</volume><issue>9</issue><fpage>H1103</fpage><lpage>11</lpage><!--<pub-id pub-id-type="pmcid">PMC4551125</pub-id>--><pub-id pub-id-type="doi">10.1152/ajpheart.00862.2014</pub-id><pub-id pub-id-type="pmid">25637549</pub-id>
</element-citation></ref><ref id="A145620REF24"><label>24</label><element-citation publication-type="journal" publication-format="print" xlink:title="Xu B, Zheng H, Liu X, Patel KP. Activation of afferent renal nerves modulates RVLM-projecting PVN neurons. Am J Physiol Heart Circ Physiol. 2015;308(9):H1103-11. [PubMed ID:25637549]. [PubMed Central ID:PMC4551125]. ."><person-group person-group-type="author"><name><surname>Ishizawa</surname><given-names>R</given-names></name><name><surname>Kim</surname><given-names>HK</given-names></name><name><surname>Hotta</surname><given-names>N</given-names></name><name><surname>Iwamoto</surname><given-names>GA</given-names></name><name><surname>Vongpatanasin</surname><given-names>W</given-names></name><name><surname>Mitchell</surname><given-names>JH</given-names></name><etal>et al.</etal></person-group><article-title>Skeletal Muscle Reflex-Induced Sympathetic Dysregulation and Sensitization of Muscle Afferents in Type 1 Diabetic Rats.</article-title><source>Hypertension.</source><year>2020</year><volume>75</volume><issue>4</issue><fpage>1072</fpage><lpage>81</lpage><!--<pub-id pub-id-type="pmcid">PMC7117783</pub-id>--><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.119.14118</pub-id><pub-id pub-id-type="pmid">32063060</pub-id>
</element-citation></ref><ref id="A145620REF25"><label>25</label><element-citation publication-type="journal" publication-format="print" xlink:title="Ishizawa R, Kim HK, Hotta N, Iwamoto GA, Vongpatanasin W, Mitchell JH, et al. Skeletal Muscle Reflex-Induced Sympathetic Dysregulation and Sensitization of Muscle Afferents in Type 1 Diabetic Rats. Hypertension. 2020;75(4):1072-81. [PubMed ID:32063060]. [PubMed Central ID:PMC7117783]. ."><person-group person-group-type="author"><name><surname>Salman</surname><given-names>IM</given-names></name><name><surname>Sarma Kandukuri</surname><given-names>D</given-names></name><name><surname>Harrison</surname><given-names>JL</given-names></name><name><surname>Hildreth</surname><given-names>CM</given-names></name><name><surname>Phillips</surname><given-names>JK</given-names></name></person-group><article-title>Direct conscious telemetry recordings demonstrate increased renal sympathetic nerve activity in rats with chronic kidney disease.</article-title><source>Front Physiol.</source><year>2015</year><volume>6</volume><fpage>218</fpage><!--<pub-id pub-id-type="pmcid">PMC4523722</pub-id>--><pub-id pub-id-type="doi">10.3389/fphys.2015.00218</pub-id><pub-id pub-id-type="pmid">26300784</pub-id>
</element-citation></ref><ref id="A145620REF26"><label>26</label><element-citation publication-type="journal" publication-format="print" xlink:title="Salman IM, Sarma Kandukuri D, Harrison JL, Hildreth CM, Phillips JK. Direct conscious telemetry recordings demonstrate increased renal sympathetic nerve activity in rats with chronic kidney disease. Front Physiol. 2015;6:218. [PubMed ID:26300784]. [PubMed Central ID:PMC4523722]. ."><person-group person-group-type="author"><name><surname>Johns</surname><given-names>EJ</given-names></name><name><surname>Kopp</surname><given-names>UC</given-names></name><name><surname>DiBona</surname><given-names>GF</given-names></name></person-group><article-title>Neural control of renal function.</article-title><source>Compr Physiol.</source><year>2011</year><volume>1</volume><issue>2</issue><fpage>731</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1002/cphy.c100043</pub-id><pub-id pub-id-type="pmid">23737201</pub-id>
</element-citation></ref></ref-list><sec><title>Authors' Contribution: </title><p>BS, MK, EB, AS, MR and MH contributed in the conception or design of the work and drafting of the manuscript. All authors confirmed the final version for submission.</p></sec><sec sec-type="COI-statement"><title>Conflict of Interests Statement: </title><p>The authors declared no conflict of interests.</p></sec><sec sec-type="data-availability"><title>Data Availability: </title><p>The study's original contributions have been included in the article's content, and the corresponding author can be contacted with further questions.</p></sec><sec><title>Ethical Approval: </title><p>This study is approved under the ethical approval code of Ethical Committee of Experimental Animals of Tehran University of Medical Sciences (IR.TUMS.MEDICINE.REC.1395.638).</p></sec><sec><title>Funding/Support: </title><p>This research was supported by the National Institute for Medical Research Development (NIMAD) (#943566).</p></sec></back></article>